Dramatically Reduce the Time and Cost of Modern Molecular Discovery
Uniting the virtual and physical with a powerful Agile AI Foundry for drug discovery.
Dramatically Reduce the Time and Cost of Modern Molecular Discovery
Uniting the virtual and physical with a powerful Agile AI Foundry for drug discovery.
Synfini dramatically reduces the time and cost of modern molecular discovery by uniting physical and virtual chemistry through expert-curated AI and discovery-focused robotic automation. We are leading drug discovery programs to the most dynamic synthesis data and designer molecules.
Synfini AI Cloud Foundry
The Synfini AI Cloud Foundry offers rapid, cost-effective access to cutting-edge, small-molecule optimization technologies. Designed to support researchers and drug hunters, Synfini simplifies the journey from target discovery to optimized drug candidates.
Discovery Workflows & Planning
Organized workflows, data and analysis for efficient discovery programs.
Generative Design
Automated Synthesis and Testing
AI-Driven Applications
Explore how Synfini’s AI-driven tools and automated workflows empower scientists across diverse stages of drug discovery. From hit discovery to lead optimization, our platform accelerates every step, enabling faster and smarter breakthroughs.
Hosted AI Models
Streamline hit discovery with custom target specific models and advanced ADME/Tox models.
Molecular Optimization
AI guided multi parameter optimization enables rapid optimization at all stage of the discovery process.
Target to Candidate
Flexible options for your in-house programs or Synfini’s curated project assets. Organized workflows, data and analysis for efficient discovery programs.
AI Driven DMTA Cycles
Fully automated workflows integrated with AI for enhanced efficiency.
The Synfini Foundry Platform and Seamless Workflow Process will:
- Dramatically accelerate drug discovery
- Help drug hunters looking for superior, faster, lower-cost research exploration
- Help find cost efficiencies nd address previously underserved 'niche' markets more effectively
- Improve drug licensing value
- Help pharma companies that are under regulatory pressure
- Discover optimized molecules and the ability to easily pivot based on an evolving biology and personalized medicine requirements
